Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Disposal

27 Apr 2006 17:09

Compagnie de Saint-Gobain27 April 2006 April 27, 2006 press release DISPOSAL OF SAINT-GOBAIN CALMAR Saint-Gobain has signed today an agreement regarding the sale of its subsidiarySaint-Gobain Calmar to MeadWestvaco Corporation. Calmar is a leading globalmanufacturer of plastic dispensing and spraying systems for cosmetics andfragrance, personal care as well as pharmaceutical industries. The transaction values Calmar at $745 million (of which $710 million in cashpaid by MeadWestvaco and $35 million of eliminated commitments by Saint-Gobain).In 2005, Calmar reported a pro-forma EBITDA of $72.7 million. Acquired by the Saint-Gobain Group in 1998, Calmar reported pro-forma sales of$403 million in 2005 and has approximately 2,700 employees based in 10production sites. Calmar will benefit from MeadWestvaco's financial capacity and global packagingstrategy, which should support its future development as a major player in itsbusiness. With annual revenues exceeding $6 billion, MeadWestvaco is a leading globalpackaging company that delivers high-value packaging solutions and products tocompanies in the food and beverage, media and entertainment, personal care,cosmetic and healthcare industries. MeadWestvaco employs approximately 23,000people around the world. The completion of the transaction, which is subject to the approval of therelevant anti-trust authorities, should be effective before the end of June2006. As it was communicated following the acquisition of BPB, the Saint-Gobain Groupis implementing a dynamic strategy of active portfolio management, consistentwith its business model. Investor Relations Department Mrs Florence TRIOU-TEIXEIRA Tel.: +33 1 47 62 45 19Mr Alexandre ETUY Tel.: +33 1 47 62 37 15 Fax.: +33 1 47 62 50 62 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Jan 20197:06 amRNSNew facility
10th Jan 20195:42 pmRNSDisposal
8th Jan 20197:12 amRNSDisposal
18th Dec 20188:48 amRNSAcquisition
30th Nov 20189:24 amRNSCancellation of shares
26th Nov 20188:21 amRNSLaunching of Transformation Program
23rd Nov 20188:23 amRNSDisposal
25th Oct 20185:02 pmRNS3rd Quarter Results
11th Oct 20183:57 pmRNSFinal Terms
10th Oct 20185:49 pmRNSFinal terms
5th Oct 20187:47 amRNSAcquisition
1st Oct 201810:43 amRNSStabilisation Notice - Compagnie de Saint-Gobain
20th Sep 20185:10 pmRNSAcquisition
20th Sep 20184:57 pmRNSFinal Terms
20th Sep 20184:56 pmRNSFinal Terms
12th Sep 20186:15 pmRNSStabilisation Notice - COMPAGNIE DE SAINT-GOBAIN
12th Sep 20185:49 pmRNSIssue of Debt
12th Sep 20188:54 amRNSStabilisation Notice - COMPAGNIE DE SAINT-GOBAIN
24th Aug 20185:21 pmRNSProspectus Supplement
1st Aug 20187:11 amRNSAcquisition
31st Jul 20185:23 pmRNSDivestment
26th Jul 20185:15 pmRNSHalf-year Report
13th Jul 20185:15 pmRNSProspectus
3rd Jul 20189:35 amRNSAcquisition
22nd Jun 20182:34 pmRNSFinal Terms
22nd Jun 20182:33 pmRNSFinal Terms
15th Jun 20188:47 amRNSCancelation of shares
24th May 20182:24 pmRNSFinal Terms
11th May 20187:00 amRNSAcquisition
26th Apr 20184:52 pmRNS1st Quarter Results
17th Apr 20184:58 pmRNSFinal Terms
13th Apr 20187:16 amRNSAcquisition
11th Apr 20185:08 pmRNSAcquisition
28th Mar 20185:02 pmRNSCapex
22nd Mar 20183:14 pmRNSIssue of Debt
19th Mar 20189:04 amRNSAcquisition
13th Mar 20184:57 pmRNSIssue of Debt
2nd Mar 20187:00 amRNSProspectus Supplement
1st Mar 20184:53 pmRNSAcquisition
22nd Feb 20185:04 pmRNS2017 Results
25th Jan 20184:52 pmRNSNew capacity
11th Jan 20185:12 pmRNSAcquisition
20th Dec 20174:50 pmRNSIssue of Debt
19th Dec 20177:27 amRNSAcquisition
6th Dec 20174:49 pmRNSAcquisition
4th Dec 20177:04 amRNSAcquisition
30th Nov 20174:55 pmRNSShares cancellation
24th Nov 20174:51 pmRNSAcquisition
23rd Nov 20176:12 pmRNSDecisions of Board of Directors
26th Oct 20176:08 pmRNSNine-months sales

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.